Oncologists' recognition of depression in their patients with cancer.

Passik, Steven D.; Dugan, William; McDonald, Margaret; Rosenfeld, Barry; Theobald, Dale; Edgerton, Sara

doi:10.1200/jco.1998.16.4.1594

Cited by 530 publications

(426 citation statements)

References 18 publications

Supporting

Mentioning

383

Contrasting

Unclassified

Order By: Relevance

“…While women do find clinics reassuring when told they do not have recurrence (Morris et al, 1992;Kiebert et al, 1993), visits are also attended by great anxiety (Paradiso et al, 1995). There is little doubt that clinicians are not good at detecting psychological problems in the clinical setting (Hardman et al, 1989;Passik et al, 1998) and patients are reluctant to report such psychological problems themselves (Valente et al, 1994;Pennery and Mallet, 2000). Certainly, one study has shown no reduction in quality of life among women randomised to receive no routine clinic visits compared with regular visits (Gulliford et al, 1997).…”

Section: Discussionmentioning

confidence: 99%

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience

et al. 2007

View full text Add to dashboard Cite

The guidelines for follow-up of breast cancer patients concentrate on the first 3 -5 years, with either reduced frequency of visits or discharge after this. They also recommend mammography, but no evidence exists to inform frequency. We analyse treatable relapses in our unit from 1312 patients with early stage breast cancer treated by breast conserving surgery (BCS) and postoperative radiotherapy between 1991 and 1998 to assess appropriateness of the guidelines. A total of 110 treatable relapses were analysed. Treatable relapse developed at 1 -1.5% per year throughout follow-up. Forty-eight relapses were in ipsilateral breast, 25 ipsilateral axilla, 35 contralateral breast, 2 both breasts simultaneously. Thirty-seven relapses (33.5%) were symptomatic, 56 (51%) mammographically detected, 15 (13.5%) clinically detected, 2 (2%) diagnosed incidentally. Mammography detected 5.37 relapses per 1000 mammograms. Patients with symptomatic or mammographically detected ipsilateral breast relapse had significantly longer survival from original diagnosis (P ¼ 0.0002) and from recurrence (P ¼ 0.0014) compared with clinically detected. Treatable relapse occurs at a constant rate for at least 10 years. Clinical examination detects a minority (13.5%). Relapse diagnosed clinically is associated with poorer outcome. Long-term follow-up based on regular mammography is warranted for all patients treated by BCS.

show abstract

Section: Discussionmentioning

confidence: 99%

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience

et al. 2007

View full text Add to dashboard Cite

show abstract

“…However, oncologists' recognition of patient distress is often poor [16,21,37,39,51]. This may explain why oncologists do not offer empathic responses as often as may be desired.…”

Section: Introductionmentioning

confidence: 99%

“What concerns me is…” Expression of emotion by advanced cancer patients during outpatient visits

Anderson

Alexander

Rodriguez

et al. 2007

Support Care Cancer

View full text Add to dashboard Cite

Objective-Cancer patients have high levels of distress, yet oncologists often do not recognize patients' concerns. We sought to describe how patients with advanced cancer verbally express negative emotion to their oncologists. Materials and methods-As part of the Studying Communication in Oncologist-PatientEncounters Trial, we audio-recorded 415 visits that 281 patients with advanced cancer made to their oncologists at three US cancer centers. Using qualitative methodology, we coded for verbal expressions of negative emotion, identified words patients used to express emotion, and categorized emotions by type and content.

show abstract

“…A large proportion of elderly cancer patients (up to 40 %) have depression, associated with high clinical and also social impact. A large prospective study showed that depressed patients have a higher risk of postoperative complications and worse survival [12,21]. Although several tools, such as the Geriatric Depression Scale, have been developed most studies have employed the psychological domain of different quality of life tests [22].…”

mentioning

confidence: 99%

On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer

Teymoortash

Halmos

Silver

et al. 2014

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Although a generally accepted definition of ''elderly'' still does not exist, in a medical context, persons over the age of 65 are often considered to be elderly. As life expectancy rates have increased within the last decades and continuously increase every year by approximately 3 months [1], this segment of the population has increased, particularly in Western countries. Because cancer is a disease of aging, the risk of developing malignant disease including head and neck cancer is highest in this patient population. It also follows that malignancy-related mortality is highest among the elderly.Younger patients with head and neck cancers have a much better overall prognosis. A comparative survival analysis revealed that patients with head and neck cancer who are aged 40 years or younger at the time of diagnosis show significantly improved 5-year survival when compared to older patients [2]. For all age groups the 5-year survival rate of patients with a newly diagnosed head and neck cancer is approximately 60 % at diagnosis. However, prognosis is a dynamic process that improves after the initial critical years of recurrence-free survival. Conditional relative survival shows clinically relevant variations according to time since diagnosis, type of cancer, and age [3]. Conditional survival rates can better analyze and reflect actual life expectancy. After 3 years of survival, the conditional survival rate improves from 60 % up to 80 %. However, long-term survival rates stagnate at 80 %. Patients cured of and neck cancer face an excess mortality of about 20 % in long-term follow-up [4]. The critical reason for this is attributed to the comorbid burden of head and neck cancer patients, connected with unhealthy habits and general lifestyle choices.Comorbidities in cancer patients are defined as one or more unrelated diseases present at the time of cancer diagnosis. Particularly in elderly patients, these predominantly consist of reduced organ and cognitive functions, malnutrition, polypharmacy, and socio-economic factors. Most studies show that approximately 60 % of head and neck cancer patients have concurrent illnesses [5]. For better evaluation of comorbidities, weighted assessment systems like Adult Comorbidity Evaluation-27 (ACE-27), and Charlson Comorbidity Index (CCI) include the occurrence of comorbidities as well as their degrees. Comorbidities exist in 46 % of head and neck cancer

show abstract

Oncologists' recognition of depression in their patients with cancer.

Cited by 530 publications

References 18 publications

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience

Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience

“What concerns me is…” Expression of emotion by advanced cancer patients during outpatient visits

On the need for comprehensive assessment of impact of comorbidity in elderly patients with head and neck cancer

Contact Info

Product

Resources

About